| In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K/A | 10-K |
| Revenues: |
| IME and other related services | 695.4 | 674.2 | 567.1 | 476.8 | 356.4 | | | |
| Peer and bill reviews, Medicare compliance and case management services | 124.2 | 101.4 | 48.9 | 44.4 | | | | |
| Peer and Bill Review Medicare Compliance and Case Management | 124.2 | 101.4 | 48.9 | 44.4 | | | | |
| Peer and bill reviews | | | | | 41.5 | | | |
| Total revenues | 819.6 | 775.6 | 616.0 | 521.2 | 397.9 | 163.5 | 49.6 | 14.7 |
| Revenue growth [+] | 5.7% | 25.9% | 18.2% | 31.0% | 143.3% | 229.4% | 237.8% | 50.2% |
| IME and other related services | 3.1% | 18.9% | 18.9% | 33.8% | | | | |
| Peer and bill reviews, Medicare compliance and case management services | 22.5% | 107.1% | 10.3% | | | | | |
| Peer and Bill Review Medicare Compliance and Case Management | 22.5% | 107.1% | 10.3% | | | | | |
| Cost of goods sold | 536.5 | 497.0 | 405.3 | 344.1 | 262.2 | 103.6 | 32.0 | 9.8 |
| Gross profit | 283.1 | 278.6 | 210.7 | 177.2 | 135.6 | 59.9 | 17.6 | 4.9 |
| Gross margin | 34.5% | 35.9% | 34.2% | 34.0% | 34.1% | 36.6% | 35.5% | 33.1% |
| Selling, general and administrative | 166.7 | 171.2 | 133.9 | 113.5 | 84.1 | 37.7 | 15.8 | 4.6 |
| Other operating expenses | | | | | | | | 2.4 |
| EBITDA [+] | 116.4 | 107.4 | 76.8 | 63.7 | 51.5 | 22.2 | 1.8 | 0.3 |
| EBITDA growth | 8.4% | 39.8% | 20.6% | 23.7% | 131.7% | 1136.3% | 602.0% | 85.5% |
| EBITDA margin | 14.2% | 13.8% | 12.5% | 12.2% | 12.9% | 13.6% | 3.6% | 1.7% |
| Depreciation | 7.0 | 6.5 | 5.7 | 5.6 | 4.0 | 1.7 | 0.7 | 2.4 |
| EBITA | 109.4 | 100.9 | 71.1 | 58.1 | 47.4 | 20.5 | 1.1 | -2.1 |
| EBITA margin | 13.4% | 13.0% | 11.5% | 11.2% | 11.9% | 12.5% | 2.2% | -14.5% |
| Amortization of intangibles | 48.7 | 53.8 | 57.0 | 53.0 | 43.4 | 17.8 | 6.2 | |
| EBIT [+] | 60.7 | 47.1 | 14.1 | 5.1 | 4.0 | 2.7 | -5.1 | -2.1 |
| EBIT growth | 28.9% | 234.8% | 174.5% | 26.7% | 49.2% | -153.2% | 138.4% | -2737.0% |
| EBIT margin | 7.4% | 6.1% | 2.3% | 1.0% | 1.0% | 1.7% | -10.3% | -14.5% |
| Interest expense | 52.5 | 32.2 | 29.6 | 28.0 | 15.5 | 8.2 | 1.8 | 0.5 |
| Interest expense | 52.5 | 32.2 | 29.6 | 28.0 | 15.5 | 8.2 | 1.8 | 0.5 |
| Other income (expense), net [+] | | | | -0.1 | -1.0 | -3.1 | -0.1 | -1.0 |
| Gain (loss) on debt retirement | 18.6 | | | | 0.6 | 3.2 | 0.5 | |
| Gain (loss) on foreign currency transactions | | | | 0.5 | 0.7 | -0.2 | | |
| Other | -52.5 | 0.2 | 0.2 | 0.2 | 16.5 | 11.2 | 1.9 | |
| Pre-tax income | 8.2 | 14.9 | -15.6 | -22.9 | -12.4 | -8.5 | -7.0 | -3.6 |
| Income taxes | 2.6 | 4.4 | -5.4 | -8.0 | -4.1 | -2.5 | -2.6 | -1.4 |
| Tax rate | 31.8% | 29.7% | 34.4% | 34.8% | 32.9% | 29.1% | 37.2% | 39.8% |
| Net income | 5.6 | 10.5 | -10.2 | -14.9 | -8.3 | -6.0 | -4.4 | -2.2 |
| Net margin | 0.7% | 1.4% | -1.7% | -2.9% | -2.1% | -3.7% | -8.9% | -14.8% |
| |
| Basic EPS [+] | $0.14 | $0.27 | ($0.29) | ($0.44) | ($0.25) | ($0.33) | ($0.42) | ($0.44) |
| Growth | -49.9% | -193.8% | -33.9% | 78.4% | -24.8% | -22.3% | -5.3% | |
| Diluted EPS [+] | $0.13 | $0.25 | ($0.29) | ($0.44) | ($0.25) | ($0.33) | ($0.42) | ($0.44) |
| Growth | -49.0% | -188.0% | -33.9% | 78.4% | -24.8% | -22.3% | -5.3% | |
| |
| Shares outstanding (basic) [+] | 41.1 | 38.7 | 35.3 | 34.1 | 34.0 | 18.5 | 10.5 | 4.9 |
| Growth | 6.4% | 9.5% | 3.4% | 0.5% | 83.6% | 76.5% | 114.0% | |
| Shares outstanding (diluted) [+] | 43.0 | 41.2 | 35.3 | 34.1 | 34.0 | 18.5 | 10.5 | 4.9 |
| Growth | 4.4% | 16.8% | 3.4% | 0.5% | 83.6% | 76.5% | 114.0% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |